What is a stock summary page? Click here for an overview.
Business Description
Avicanna Inc
NAICS : 325411
SIC : 3741
ISIN : CA05368K1003
Share Class Description:
AVCNF: Ordinary SharesCompare
Compare
Traded in other countries / regions
AVCN.CanadaAVCNF.USA0NN.Germany IPO Date
2019-08-22Description
Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.55 | |||||
| Equity-to-Asset | 0.08 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -4.99 | |||||
| Beneish M-Score | -3.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 55.2 | |||||
| 3-Year EBITDA Growth Rate | 57.7 | |||||
| 3-Year EPS without NRI Growth Rate | 46 | |||||
| 3-Year FCF Growth Rate | 64.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.28 | |||||
| 9-Day RSI | 37.68 | |||||
| 14-Day RSI | 44.74 | |||||
| 3-1 Month Momentum % | 5.32 | |||||
| 6-1 Month Momentum % | -10.96 | |||||
| 12-1 Month Momentum % | -45.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.83 | |||||
| Quick Ratio | 0.43 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 115.72 | |||||
| Days Sales Outstanding | 45.57 | |||||
| Days Payable | 216.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -36.2 | |||||
| Shareholder Yield % | -8.82 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.86 | |||||
| Operating Margin % | -25.15 | |||||
| Net Margin % | -27.31 | |||||
| FCF Margin % | -13.19 | |||||
| ROE % | -1580.66 | |||||
| ROA % | -31.47 | |||||
| ROIC % | -39.84 | |||||
| 3-Year ROIIC % | -104.48 | |||||
| ROC (Joel Greenblatt) % | -53.96 | |||||
| ROCE % | -66.65 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 14.14 | |||||
| PS Ratio | 1.24 | |||||
| PB Ratio | 20.31 | |||||
| EV-to-EBIT | -6.72 | |||||
| EV-to-EBITDA | -7.82 | |||||
| EV-to-Revenue | 1.71 | |||||
| EV-to-Forward-Revenue | 2.21 | |||||
| EV-to-FCF | -12.88 | |||||
| Price-to-GF-Value | 0.37 | |||||
| Earnings Yield (Greenblatt) % | -14.88 | |||||
| FCF Yield % | -9.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AVCNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avicanna Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 18.374 | ||
| EPS (TTM) ($) | -0.076 | ||
| Beta | 1.3 | ||
| 3-Year Sharpe Ratio | 0.1 | ||
| 3-Year Sortino Ratio | 0.16 | ||
| Volatility % | 81.11 | ||
| 14-Day RSI | 44.74 | ||
| 14-Day ATR ($) | 0.013386 | ||
| 20-Day SMA ($) | 0.23408 | ||
| 12-1 Month Momentum % | -45.43 | ||
| 52-Week Range ($) | 0.1345 - 0.4 | ||
| Shares Outstanding (Mil) | 109.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avicanna Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avicanna Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avicanna Inc Frequently Asked Questions
What is Avicanna Inc(AVCNF)'s stock price today?
The current price of AVCNF is $0.21. The 52 week high of AVCNF is $0.40 and 52 week low is $0.13.
When is next earnings date of Avicanna Inc(AVCNF)?
The next earnings date of Avicanna Inc(AVCNF) is .
Does Avicanna Inc(AVCNF) pay dividends? If so, how much?
Avicanna Inc(AVCNF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers